Preparation, biochemical characterization and biological properties of radiolabelled N-alkylated deoxynojirimycins

被引:66
作者
Mellor, HR
Nolan, J
Pickering, L
Wormald, MR
Platt, FM
Dwek, RA
Fleet, GWJ
Butters, TD
机构
[1] Univ Oxford, Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England
[2] Amersham Pharm Biotech, Amersham Labs, Amersham HP7 9LL, Bucks, England
[3] Univ Oxford, Dyson Perrins Lab, Oxford OX1 3QQ, England
关键词
glucosyltransforase; hydrophobic; imino sugar; inhibitor; tissue uptake;
D O I
10.1042/BJ20020466
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have reductively alkylated deoxynojirimycin imino sugars using sodium cyanoborohydride to provide an efficient means of generating a series of N-alkylated compounds containing 4-18 carbon side chains, The yields were greater than 90 % using a variety of aldehydes of different chain lengths, and after purification were > 95% pure using H-1-NMR. Radiolabelled compounds were prepared using sodium cyanoborotriti-ide to selectively label the first carbon atom in the alkyl chain and used in protein-binding and cell- and tissue-uptake experiments. Protein binding was chain-length-dependent with compounds of intermediate chain length (C-9-C-12), demonstrating an equal distribution between the aqueous and protein-bound phase. The extent of cell uptake also increased proportionally with increased chain length in a time-dependent manner. When administered to mice, the longer alkyl-chain compounds showed reduced absorption from the intestine and a marked deposition of compound in the liver and brain, suggesting that the more hydrophobic compounds were poorly cleared by the major tissues. In tissue-culture cells compounds with 8 or fewer carbon atoms were nontoxic and had CC50 (the concentration at which the number of cells or cell proliferation is reduced by 50 %.) values greater than 1 mM. Compounds with chain lengths above C, showed a chain-length-dependent increase in cytotoxicity. N-alkylated deoxynojirimycins (C-4-C-18) were evaluated for their inhibitory effects on ceramide-specific glucosyltransferase and glycoprotein-processing alpha-glucosidase. Increasing the alkyl chain length had little effect on a-glucosidase activity, but inhibition of ceramide-specific glucosyltransferase increased 10-fold when C-4 and C-9-C-18 compounds were compared. Overall these data provide further definition of the molecular features of alkylated imino sugars that influence tissue selectivity and efficacy for cellular enzyme inhibition.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 27 条
[1]   Membrane proteins implicated in long-chain fatty acid uptake by mammalian cells: CD36, FATP and FABPm [J].
Abumrad, N ;
Coburn, C ;
Ibrahimi, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 1999, 1441 (01) :4-13
[2]   N-butyldeoxygalactonojirimycin:: A more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo [J].
Andersson, U ;
Butters, TD ;
Dwek, RA ;
Platt, FM .
BIOCHEMICAL PHARMACOLOGY, 2000, 59 (07) :821-829
[3]  
BIA J, 1997, BIOCHEMISTRY-US, V36, P8840
[4]   Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking [J].
Block, TM ;
Lu, XY ;
Mehta, AS ;
Blumberg, BS ;
Tennant, B ;
Ebling, M ;
Korba, B ;
Lansky, DM ;
Jacob, GS ;
Dwek, RA .
NATURE MEDICINE, 1998, 4 (05) :610-614
[5]   THE ANTIGLYCOGENOLYTIC ACTION OF 1-DEOXYNOJIRIMYCIN RESULTS FROM A SPECIFIC-INHIBITION OF THE ALPHA-1,6-GLUCOSIDASE ACTIVITY OF THE DEBRANCHING ENZYME [J].
BOLLEN, M ;
STALMANS, W .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 181 (03) :775-780
[6]  
Booth Paula J., 1999, Current Opinion in Structural Biology, V9, P115, DOI 10.1016/S0959-440X(99)80015-3
[7]   ABC transporters in lipid transport [J].
Borst, P ;
Zelcer, N ;
van Helvoort, A .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1486 (01) :128-144
[8]   Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis [J].
Butters, TD ;
van den Broek, LAGM ;
Fleet, GWJ ;
Krulle, TM ;
Wormald, MR ;
Dwek, RA ;
Platt, FM .
TETRAHEDRON-ASYMMETRY, 2000, 11 (01) :113-124
[9]  
BUTTERS TD, 1981, IN VITRO CELL DEV B, V17, P831, DOI 10.1007/BF02618451
[10]   Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis [J].
Cox, T ;
Lachmann, R ;
Hollak, C ;
Aerts, J ;
van Weely, S ;
Hrebícek, M ;
Platt, F ;
Butters, T ;
Dwek, R ;
Moyses, C ;
Gow, I ;
Elstein, D ;
Zimran, A .
LANCET, 2000, 355 (9214) :1481-1485